Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors

被引:98
作者
Jacobson, A [1 ]
Rahmanian, M [1 ]
Rubin, K [1 ]
Heldin, P [1 ]
机构
[1] Uppsala Univ, Dept Med Biochem & Microbiol, Ctr Biomed, S-75122 Uppsala, Sweden
关键词
hyaluronan synthase; hyaluronidase; colon carcinoma; tumorigenicity;
D O I
10.1002/ijc.10683
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Advanced colorectal cancers are often associated with elevated amounts of hyaluronan. To investigate the importance of hyaluronan in colon carcinoma tumor progression, we have expressed by stable transfection hyaluronan synthase 2 (Has2) and hyaluronidase I (Hyal I) in the rat colon carcinoma cell line, PROb. We found that hyaluronan overproduction led to a higher growth rate of tumor cells in vitro, and to a faster development of transplantable tumors in syngeneic rats, compared to the mock-transfectants. Has2 transfected PROb cells gave rise to tumors that were significantly less vascularized, but had a significantly larger viable tumor fraction compared to tumors generated from mock-transfectants. In contrast, HyaII overexpression suppressed the growth rate of tumor cells both in vitro and in vivo. Moreover, tumors derived from HyaII-transfected cells had a significantly larger necrotic area than tumors derived from mock- and Has2-transfectants. Our study demonstrates that Has2 overproduction promotes tumorigenicity, whereas HyaII overexpression suppresses tumorigenicity in an experimental model for colon carcinoma. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 57 条
[1]  
[Anonymous], 1989, CIBA F SYMP
[2]  
ASPLUND T, 1994, CANCER RES, V54, P4516
[3]   LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan [J].
Banerji, S ;
Ni, J ;
Wang, SX ;
Clasper, S ;
Su, J ;
Tammi, R ;
Jones, M ;
Jackson, DG .
JOURNAL OF CELL BIOLOGY, 1999, 144 (04) :789-801
[4]   INTERACTION BETWEEN CD44 AND HYALURONATE IS DIRECTLY IMPLICATED IN THE REGULATION OF TUMOR-DEVELOPMENT [J].
BARTOLAZZI, A ;
PEACH, R ;
ARUFFO, A ;
STAMENKOVIC, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :53-66
[5]   Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44 [J].
Brinck, J ;
Heldin, P .
EXPERIMENTAL CELL RESEARCH, 1999, 252 (02) :342-351
[6]   Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme [J].
Camenisch, TD ;
Spicer, AP ;
Brehm-Gibson, T ;
Biesterfeldt, J ;
Augustine, ML ;
Calabro, A ;
Kubalak, S ;
Klewer, SE ;
McDonald, JA .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (03) :349-360
[7]   p53 overexpression and downregulation of inter-α-inhibitor are associated with hyaluronidase enhancement of TNF cytotoxicity in L929 fibroblasts [J].
Chang, NS ;
Carey, G ;
Pratt, N ;
Chu, E ;
Ou, M .
CANCER LETTERS, 1998, 131 (01) :45-54
[8]   The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus [J].
Csóka, TB ;
Frost, GI ;
Heng, HHQ ;
Scherer, SW ;
Mohapatra, G ;
Stern, R .
GENOMICS, 1998, 48 (01) :63-70
[9]  
Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO
[10]  
2-J